These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2539182)

  • 1. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
    Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
    Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
    Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro.
    Wiener E; Dellow RA; Mawas F; Rodeck CH
    Transfus Med; 1996 Sep; 6(3):235-41. PubMed ID: 8885153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM
    Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaction of rheumatoid factors with IgG3 monoclonal anti-Rh(D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5).
    Puttick AH; Williamson EA; Merry AH; Kumpel BM; Thompson KM; Jones VE
    Ann Rheum Dis; 1988 Nov; 47(11):898-905. PubMed ID: 3207373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
    Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
    Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fc gamma receptors.
    Kumpel BM; van de Winkel JG; Westerdaal NA; Hadley AG; Dugoujon JM; Blancher A
    Br J Haematol; 1996 Jul; 94(1):175-83. PubMed ID: 8757532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
    Kumpel BM; Hadley AG
    Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21).
    Jones VE; Puttick AH; Williamson EA; Mageed RA
    Clin Exp Immunol; 1988 Mar; 71(3):451-8. PubMed ID: 3383449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.
    Walker MR; Lund J; Thompson KM; Jefferis R
    Biochem J; 1989 Apr; 259(2):347-53. PubMed ID: 2524188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activity of human Rh monoclonal antibodies (MABS).
    Kumpel BM
    J Immunogenet; 1990; 17(4-5):321-30. PubMed ID: 2128776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.
    Hadley AG; Kumpel BM
    Immunology; 1989 Aug; 67(4):550-2. PubMed ID: 2504663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis.
    Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA
    Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
    PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.